ClinicalTrials.gov
public full text
Public Domain
The Prospective Non-randomized Case-control Study From Real-world Lung Cancer Patients
The pragmatic clinical trial to elucidate optimal target population of immunotherapy from real-world lung cancer patients
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels#272345
- A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)#992895
- Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer#853006
- Efficacy and Safety of Immunotherapy in Non-small Cell Lung Cancer With Uncommon Histological Type#363599
- Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer#366607
Record · ID 844548
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive